| Unique ID issued by UMIN | UMIN000058416 |
|---|---|
| Receipt number | R000066791 |
| Scientific Title | Evaluation of long-term rehabilitation and nutritional management for tailored medicine after esophageal cancer surgery |
| Date of disclosure of the study information | 2025/07/10 |
| Last modified on | 2025/07/10 02:01:53 |
Evaluation of long-term rehabilitation and nutritional management
for tailored medicine after esophageal cancer surgery
Evaluation of long-term rehabilitation and nutritional management
for tailored medicine after esophageal cancer surgery
Evaluation of long-term rehabilitation and nutritional management
for tailored medicine after esophageal cancer surgery
Evaluation of long-term rehabilitation and nutritional management
for tailored medicine after esophageal cancer surgery
| Japan |
Thoracic esophageal cancer
| Gastrointestinal surgery |
Malignancy
NO
To examine the temporal recovery from surgical trauma in patients undergoing surgery for esophageal cancer and to clarify the current effectiveness of outpatient rehabilitation and nutritional interventions, thereby identifying issues and determining the groups requiring active intervention and the appropriate intervention methods.
Safety,Efficacy
Confirmatory
Explanatory
Phase II
Relationship between rehabilitation intervention outcomes and improved nutritional assessment
1) Compliance rate with rehabilitation
2) Changes in nutritional indicators
3) Identification of groups requiring rehabilitation and nutritional intervention
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Maneuver |
This study aims to clarify how physical performance, body composition analysis, physical activity measured by a pedometer, nutritional intake, and nutritional indicators measured by blood tests change from the start of treatment to one year after surgery.
| 20 | years-old | <= |
| 80 | years-old | > |
Male and Female
1) The primary tumor is located in the neck, thoracic esophagus, or esophagogastric junction (UICC-TNM 8th edition).
2) Pathologically diagnosed as squamous cell carcinoma, adenocarcinoma, or basaloid carcinoma.
3) Preoperative adjuvant therapy (chemotherapy, chemoradiotherapy) and curative thoracotomy or laparotomy (including laparoscopic surgery) are planned.
4) Written informed consent has been obtained from the patient.
5) Age 20 years or older and 80 years or younger.
6) Performance status (PS) is 0 or 1.
7) No active concurrent cancer.
8) Organ function is preserved.
1) If consent to participate in the trial cannot be obtained
2) If regular hospital visits are difficult
60
| 1st name | Hiroshi |
| Middle name | |
| Last name | Sato |
Saitama Medical Uniersity International Medical Center
Gastroenterological surgery
3501298
1397-1 Yamane, Hidaka-shi, Saitama
+81-42-984-4111
hs8401@5931.saitama-med.ac.jp
| 1st name | HIROSHI |
| Middle name | |
| Last name | SATO |
Saitama Medical Uniersity International Medical Center
Gastroenterological surgery
350-1298
1397-1 Yamane, Hidaka-shi, Saitama
0429844111
hs8401@5931.saitama-med.ac.jp
Saiatama Medical University
Hiroshi Sato
Japan Science and Technology Agency
Japanese Governmental office
Saitama Medical University International Medical Center Clinical Research IRB
1397-1 Yamane, Hidaka-shi, Saitama
+81-42-984-4111
imc_irb@saitama-med.ac.jp
NO
| 2025 | Year | 07 | Month | 10 | Day |
Unpublished
32
No longer recruiting
| 2022 | Year | 02 | Month | 25 | Day |
| 2022 | Year | 05 | Month | 18 | Day |
| 2022 | Year | 05 | Month | 18 | Day |
| 2024 | Year | 12 | Month | 31 | Day |
| 2026 | Year | 06 | Month | 30 | Day |
| 2025 | Year | 07 | Month | 10 | Day |
| 2025 | Year | 07 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066791